FDA vaccine director flagged concerns over "hyper-accelerated" review of Pfizer's Covid-19 vaccine
![Photo: Manuel Balce Ceneta/AP/Ritzau Scanpix](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/14890757/o5ne9x/ALTERNATES/schema-16_9/22353823659091-5708x3214ma.jpg)
Had the decision been left to the US Food and Drug Administration’s former director of vaccine research and review, Marion Gruber, Pfizer’s Covid-19 jab would never have received accelerated review at all, reports media Endpoints News. Before it happened, she said in a hitherto unpublicized email sent to other FDA officials that fast-tracking the approval process would undermine public trust in the Covid-19 vaccine.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.